SCHEMBL4599588

SCHEMBL4599588

CCNc1[c]ccc(OS(C)(=O)=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 3/20 0.36
GAA P10253 2/20 0.33
HPGD P15428 2/20 0.33
CA2 P00918 3/20 0.32
CA5A P35218 2/20 0.32
FAAH O00519 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
ALPL P05186 1/20 0.31
ALPI P09923 1/20 0.31
MMP1 P03956 1/20 0.31
MMP2 P08253 1/20 0.31
MMP7 P09237 1/20 0.31
MMP9 P14780 1/20 0.31
MMP14 P50281 1/20 0.31
CA12 O43570 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4598887 0.82 CA12 (0.35) KDM4EALDH1A1GAAHPGDCA2
SCHEMBL4599912 0.82 ALDH1A1 (0.38) KDM4EALDH1A1GAAHPGDCA2
SCHEMBL4598688 0.81 TDP1 (0.43) ALDH1A1GAAFAAHLMNAMAPT
SCHEMBL4599391 0.81 HTT (0.40) ALDH1A1CA2FAAHLMNAMAPT
SCHEMBL3454513 0.80 MEN1 (0.44) ALDH1A1GAAHPGDCA2LMNA
SCHEMBL4599803 0.78 ALDH1A1 (0.42) KDM4EALDH1A1GAAHPGDCA2
SCHEMBL4600346 0.76 APLNR (0.48) ALDH1A1LMNA
SCHEMBL28387862 0.73 ALDH1A1 (0.41) KDM4EALDH1A1GAAHPGDCA2
SCHEMBL15067718 0.73 HPGD (0.41) KDM4EALDH1A1GAAHPGDCA2
SCHEMBL15066795 0.71 ALDH1A1 (0.40) KDM4EALDH1A1GAAHPGDCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP claimed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO claimed
EP-1910320-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF Mitsubishi Tanabe Pharma Corporation (JP) 2008-04-16 EP disclosed
WO-2007011065-A2 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2007-01-25 WO disclosed